risks of glp 1 agonists 📌 Anesthetic associated with the use implantable Glucagon-like Peptide (GLP-1): case report 👥 Authors: Marcelo de Jesus Martins, Stefania Lacerda Garcia, Rafael Pereira Espínola, Caroline Paiva Matos Oliveira Martin Benefit-Risk Assessment of GLP-1 Receptor

Presented for research literature review only Gibb Z et al

Starting a new peptide can trigger hypervigilance

Certificate of Analysis & Safety Data What researchers are saying Excellent recommendation from Cody

a RWD: real-world data from cohort or registry studies (electronic health records, insurance-claims databases), b SRS: adverse drug reaction evidence from case reports and spontaneous-reporting systems, such as the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and World Health Organization (WHO) VigiBase

I feel more comfortable and in control of my joint health than ever. Liam Smith, 42 Four months ago, my arthritis pain was so bad I could barely climb into my truck